| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/26/2011 | US20110123528 Humanized anti-factor d antibodies and uses thereof |
| 05/26/2011 | US20110123517 Dissolvable pharmaceutical implant |
| 05/26/2011 | US20110123514 Angiogenin-enriched milk fractions |
| 05/26/2011 | US20110123496 Bismacrocyclic compounds as hepatitis c virus inhibitors |
| 05/26/2011 | US20110123493 2,4,6-TRISUBSTITUTED PYRIDO(3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
| 05/26/2011 | US20110123491 Methods and compositions for immunization against chlamydial infection and disease |
| 05/26/2011 | US20110123490 Heterocyclic antiviral compounds |
| 05/26/2011 | US20110123489 Heterocyclic antiviral compounds |
| 05/26/2011 | US20110123485 Viral vectors for delivering vaccines for hiv and other infectious diseases |
| 05/26/2011 | US20110123481 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
| 05/26/2011 | US20110123470 Natural bioactive compounds |
| 05/26/2011 | US20110123464 Stabilization of body-care and household products |
| 05/26/2011 | US20110123459 Anaerobic Iodine Solution |
| 05/26/2011 | US20110123451 Method for Cell Delivery Using Targeted Liposomes Associated with a Hemolysin |
| 05/26/2011 | US20110123436 Dock-and-Lock (DNL) Complexes for Delivery of Interference RNA |
| 05/26/2011 | US20110123435 Compounds for inhibiting ksp kinesin activity |
| 05/26/2011 | US20110120475 Topical antiviral formulations |
| 05/26/2011 | DE102009054302A1 Chinazolinderivate Quinazoline derivatives |
| 05/26/2011 | DE102009053946A1 Medicament, useful for treating infections caused by influenza virus, preferably strain H1N1, in humans, comprises clarithromycin or its salt, solvate or hydrate |
| 05/26/2011 | CA2793751A1 Quadruple therapy useful for treating persons afflicted with the human immunodeficiency virus (hiv) |
| 05/26/2011 | CA2793749A1 Novel schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (hiv) |
| 05/26/2011 | CA2785376A1 Pharmaceutical composition |
| 05/26/2011 | CA2781669A1 Cyclodextrin-based polymers for therapeutic delivery |
| 05/26/2011 | CA2781666A1 Lipopeptide compositions and related methods |
| 05/26/2011 | CA2781550A1 Antimicrobial compositions containing free fatty acids |
| 05/26/2011 | CA2781397A1 Compositions, methods and uses for poxvirus elements in vaccine constructs |
| 05/26/2011 | CA2781384A1 Biofilm disruptive compositions |
| 05/26/2011 | CA2780912A1 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
| 05/26/2011 | CA2780487A1 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| 05/26/2011 | CA2780207A1 Low antigen-dose immunization for maximizing t-helper cell 1 (th1) immunity against disease |
| 05/26/2011 | CA2778206A1 Heterocyclic antiviral compounds |
| 05/26/2011 | CA2776849A1 Novel heterocyclic acrylamides and their use as pharmaceuticals |
| 05/26/2011 | CA2774094A1 Formulations of daptomycin |
| 05/25/2011 | EP2325196A1 Replikin peptides and uses thereof |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324840A1 Production of caffeoylquinic acids from plant cell cultures of echinacea angustifolia |
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2324812A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 05/25/2011 | EP2324110A2 Elimination of a contaminating non-human sialic acid by metabolic competition |
| 05/25/2011 | EP2324062A1 Chimeric respiratory syncytial virus polypeptide antigens |
| 05/25/2011 | EP2324043A1 Nucleoside derivatives as inhibitors of viral polymerases |
| 05/25/2011 | EP2324041A2 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 05/25/2011 | EP2324016A1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 05/25/2011 | EP2323690A1 Delivery of a cd40 agonist to a tumor draining lymph node of a subject |
| 05/25/2011 | EP2323684A2 Use of a pneumococcal p4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 05/25/2011 | EP2323680A2 Proteins for use in diagnosing and treating infection and disease |
| 05/25/2011 | EP2323679A2 Clip inhibitors and methods of modulating immune function |
| 05/25/2011 | EP2323674A2 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 05/25/2011 | EP2323673A1 Antimicrobial silver solutions |
| 05/25/2011 | EP2323660A2 Small molecule inhibitors of retroviral assembly and maturation |
| 05/25/2011 | EP2323651A2 Compounds for the treatment of flaviviral infections |
| 05/25/2011 | EP2323643A1 Composition and method for treatment of mrsa |
| 05/25/2011 | EP2114406B1 Thioxanthene derivates as sole anti-infective agents for use in the treatment of infectious diseases |
| 05/25/2011 | EP2082750B1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 05/25/2011 | EP1697400B1 Biphenyl-substituted antibacterial macrocycles |
| 05/25/2011 | EP1664118B1 Tlr2 antagonistic antibody and use thereof |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1349562B1 Inhibiting gs-fdh to modulate no bioactivity |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | EP1294361B1 Compositions and methods to improve the oral absorption of antimicrobial agents |
| 05/25/2011 | CN201840679U External bacteriostatic tablet for gynaecology |
| 05/25/2011 | CN1980674B Phthalazine derivatives as parp inhibitors |
| 05/25/2011 | CN1816538B Preventive or therapeutic composition for viral infectious disease |
| 05/25/2011 | CN1813872B Liver-reinforcing and toxin-dispelling capsule for treating heptitis B and its preparing process |
| 05/25/2011 | CN1416352B Outer membrane vesicle (OMV) vaccine comprising N. Meningitidis serogroup B outer membrane |
| 05/25/2011 | CN102076707A Caspofungin free of caspofungin impurity A |
| 05/25/2011 | CN102076686A Diketopiperidine derivatives as HIV attachment inhibitors |
| 05/25/2011 | CN102076683A Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives |
| 05/25/2011 | CN102076361A Probiotics, secretory IgA and infection |
| 05/25/2011 | CN102076360A Probiotics, secretory IgA and inflammation |
| 05/25/2011 | CN102076359A Vaccine compositions and methods |
| 05/25/2011 | CN102076357A Microneedle device, and method for enhancing efficacy of influenza vaccine by using microneedle devive |
| 05/25/2011 | CN102071461A Method for preparing titanium dioxide nanometer tubes and titanium dioxide nanometer tube preparation for loading enrofloxacin animal remedy |
| 05/25/2011 | CN102071219A Improved AAV2 (Adeno-Associated Virus II) vector and application thereof in medicine for preventing and treating AIDS (Acquired Immure Deficiency Syndrome) |
| 05/25/2011 | CN102071204A Deoxyribonucleic acid (DNA) aptamer for mycobacterium tuberculosis glycolipid antigen and application thereof |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070711A Tissue factor pathway inhibitor (TFPI), preparation method thereof and application thereof |
| 05/25/2011 | CN102070704A Entire gene sequence of severe fever with thrombocytopenia syndrome virus (SFTSV) and application |
| 05/25/2011 | CN102070703A Methods for preparing purified daptomycin |
| 05/25/2011 | CN102070670A Purine derivatives for treating hepatitis B and preparation method and application thereof |
| 05/25/2011 | CN102070656A Substituted imidazole ring-containing cephalosporin derivatives |
| 05/25/2011 | CN102070655A Imidazole ring-containing cephalosporin derivative |
| 05/25/2011 | CN102070631A Quaternary ammonium salt of penehyclidine optical isomer, medicinal composition and medical application thereof |
| 05/25/2011 | CN102070595A Substituted benzoxanthone type compound and application thereof |
| 05/25/2011 | CN102070588A Alpha-pyrone compounds, and preparation method and application thereof |
| 05/25/2011 | CN102070549A 5-substituted-2-(4-substituted phenyl)benzoxazole derivatives and preparation method and application thereof |
| 05/25/2011 | CN102070481A Medicine tromantadine with adamantane structure, anti-tumor application of derivates and analogs thereof having new indications |
| 05/25/2011 | CN102070463A Medicine memantine with adamantane structure, and derivative and analog thereof, and application to new antineoplastic indication |
| 05/25/2011 | CN102070432A Novel preparation method for hypocrellin B serving as photosensitizer |
| 05/25/2011 | CN102068698A Nanometer vaccine and preparation method thereof |
| 05/25/2011 | CN102068695A Method for producing quadruple inactivated vaccine for newcastle disease, infectious bronchitis, avian influenza (H9 subtype) and infectious bursal disease |
| 05/25/2011 | CN102068694A Method for producing triple inactivated vaccine for newcastle disease, infectious bronchitis and infectious bursal disease |
| 05/25/2011 | CN102068692A Influenza virus splitting vaccine and preparation method thereof |
| 05/25/2011 | CN102068691A Method for preparing high purity hand-foot-and-mouth disease vaccine with sucrose zonal ultracentrifugation |
| 05/25/2011 | CN102068690A Polyvalent pneumococcal capsular polysaccharide conjugate vaccine and preparation method thereof |
| 05/25/2011 | CN102068671A Anti-human immunodeficiency virus (HIV) pure natural plant specific traditional Chinese medicine |
| 05/25/2011 | CN102068667A Chinese medicine composition with clearing heat and detoxicating functions |
| 05/25/2011 | CN102068658A Chinese medicine composite for clearing heat, detoxicating, dispelling dampness and eliminating stagnation and preparation method thereof |
| 05/25/2011 | CN102068643A External Chinese medicament for treating onychomycosis |
| 05/25/2011 | CN102068642A Medicinal composition for treating skin tinea and preparation method and application thereof |